FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3117456670> ?p ?o ?g. }

• W3117456670 endingPage "241" @default.
• W3117456670 startingPage "241" @default.
• W3117456670 abstract "Delta-like-ligand 4 (DLL4) is a promising target to augment the effects of VEGF inhibitors. A simultaneous blockade of VEGF/VEGFR and DLL4/Notch signaling pathways leads to more potent anti-cancer effects by synergistic anti-angiogenic mechanisms in xenograft models. A bispecific antibody targeting VEGF and DLL4 (ABL001/NOV1501/TR009) demonstrates more potent in vitro and in vivo biological activity compared to VEGF or DLL4 targeting monoclonal antibodies alone and is currently being evaluated in a phase 1 clinical study of heavy chemotherapy or targeted therapy pre-treated cancer patients (ClinicalTrials.gov Identifier: NCT03292783). However, the effects of a combination of ABL001 and chemotherapy on tumor vessels and tumors are not known. Hence, the effects of ABL001, with or without paclitaxel and irinotecan were evaluated in human gastric or colon cancer xenograft models. The combination treatment synergistically inhibited tumor progression compared to each monotherapy. More tumor vessel regression and apoptotic tumor cell induction were observed in tumors treated with the combination therapy, which might be due to tumor vessel normalization. Overall, these findings suggest that the combination therapy of ABL001 with paclitaxel or irinotecan would be a better clinical strategy for the treatment of cancer patients." @default.
• W3117456670 created "2021-01-05" @default.
• W3117456670 creator A5002426660 @default.
• W3117456670 creator A5004574361 @default.
• W3117456670 creator A5019886336 @default.
• W3117456670 creator A5028172313 @default.
• W3117456670 creator A5033521019 @default.
• W3117456670 creator A5044259268 @default.
• W3117456670 creator A5049299616 @default.
• W3117456670 creator A5055254594 @default.
• W3117456670 creator A5061808243 @default.
• W3117456670 creator A5075356818 @default.
• W3117456670 creator A5080704969 @default.
• W3117456670 creator A5083663537 @default.
• W3117456670 date "2020-12-29" @default.
• W3117456670 modified "2023-10-17" @default.
• W3117456670 title "ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models" @default.
• W3117456670 cites W1967600348 @default.
• W3117456670 cites W1975044445 @default.
• W3117456670 cites W1975391225 @default.
• W3117456670 cites W1987662957 @default.
• W3117456670 cites W2011979694 @default.
• W3117456670 cites W2017322644 @default.
• W3117456670 cites W2036329032 @default.
• W3117456670 cites W2056285082 @default.
• W3117456670 cites W2069496194 @default.
• W3117456670 cites W2073143902 @default.
• W3117456670 cites W2096939480 @default.
• W3117456670 cites W2099028752 @default.
• W3117456670 cites W2102497054 @default.
• W3117456670 cites W2124396025 @default.
• W3117456670 cites W2128295200 @default.
• W3117456670 cites W2129186320 @default.
• W3117456670 cites W2131933367 @default.
• W3117456670 cites W2134698258 @default.
• W3117456670 cites W2141046053 @default.
• W3117456670 cites W2143874982 @default.
• W3117456670 cites W2150654884 @default.
• W3117456670 cites W2160947862 @default.
• W3117456670 cites W2162352067 @default.
• W3117456670 cites W2165526979 @default.
• W3117456670 cites W2314160543 @default.
• W3117456670 cites W2332974012 @default.
• W3117456670 cites W2767856817 @default.
• W3117456670 cites W2770920742 @default.
• W3117456670 cites W2774533844 @default.
• W3117456670 cites W2793943975 @default.
• W3117456670 cites W2805354595 @default.
• W3117456670 cites W2884141826 @default.
• W3117456670 cites W2911812451 @default.
• W3117456670 cites W2913745075 @default.
• W3117456670 cites W2947359896 @default.
• W3117456670 cites W2973393386 @default.
• W3117456670 cites W2984238186 @default.
• W3117456670 cites W3003714437 @default.
• W3117456670 cites W3025022288 @default.
• W3117456670 cites W3037217467 @default.
• W3117456670 cites W3096667135 @default.
• W3117456670 cites W4252851641 @default.
• W3117456670 doi "https://doi.org/10.3390/ijms22010241" @default.
• W3117456670 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7796106" @default.
• W3117456670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33383646" @default.
• W3117456670 hasPublicationYear "2020" @default.
• W3117456670 type Work @default.
• W3117456670 sameAs 3117456670 @default.
• W3117456670 citedByCount "20" @default.
• W3117456670 countsByYear W31174566702021 @default.
• W3117456670 countsByYear W31174566702022 @default.
• W3117456670 countsByYear W31174566702023 @default.
• W3117456670 crossrefType "journal-article" @default.
• W3117456670 hasAuthorship W3117456670A5002426660 @default.
• W3117456670 hasAuthorship W3117456670A5004574361 @default.
• W3117456670 hasAuthorship W3117456670A5019886336 @default.
• W3117456670 hasAuthorship W3117456670A5028172313 @default.
• W3117456670 hasAuthorship W3117456670A5033521019 @default.
• W3117456670 hasAuthorship W3117456670A5044259268 @default.
• W3117456670 hasAuthorship W3117456670A5049299616 @default.
• W3117456670 hasAuthorship W3117456670A5055254594 @default.
• W3117456670 hasAuthorship W3117456670A5061808243 @default.
• W3117456670 hasAuthorship W3117456670A5075356818 @default.
• W3117456670 hasAuthorship W3117456670A5080704969 @default.
• W3117456670 hasAuthorship W3117456670A5083663537 @default.
• W3117456670 hasBestOaLocation W31174566701 @default.
• W3117456670 hasConcept C121608353 @default.
• W3117456670 hasConcept C126322002 @default.
• W3117456670 hasConcept C143998085 @default.
• W3117456670 hasConcept C150903083 @default.
• W3117456670 hasConcept C159654299 @default.
• W3117456670 hasConcept C203014093 @default.
• W3117456670 hasConcept C207001950 @default.
• W3117456670 hasConcept C2776107976 @default.
• W3117456670 hasConcept C2776694085 @default.
• W3117456670 hasConcept C2776999253 @default.
• W3117456670 hasConcept C2777292972 @default.
• W3117456670 hasConcept C2777802072 @default.
• W3117456670 hasConcept C2779551604 @default.
• W3117456670 hasConcept C2780259306 @default.
• W3117456670 hasConcept C502942594 @default.

• next